APOE modifies the association between Aβ load and cognition in cognitively normal older adults.
about
Chocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsUshering in the study and treatment of preclinical Alzheimer diseaseFuture Directions in Imaging Neurodegeneration.Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.Longitudinal change in working memory as a function of APOE genotype in midlife and old age.Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.Early detection of Alzheimer's disease using PiB and FDG PETMolecular imaging of Alzheimer disease pathologySynergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.The evolution of preclinical Alzheimer's disease: implications for prevention trials.Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.Microstructural White Matter Properties Mediate the Association between APOE and Perceptual Speed in Very Old Persons without Dementia.Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseAPOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented eldersRelationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.Indicators of amyloid burden in a population-based study of cognitively normal elderly.Relation of neuropathology to cognition in persons without cognitive impairment.Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's diseaseNeuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment.Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the CommunityAmyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individualsIndependent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive ImpairmentApolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.Preclinical Alzheimer disease-the challenges ahead.Individual estimates of age at detectable amyloid onset for risk factor assessment.
P2860
Q26738827-7407214D-6E26-4597-A909-B3B1F3AF964DQ26801647-6775199A-8B87-4FF4-A48D-504123B64E85Q26830467-447B0BF5-7D01-457C-8954-E0AC9CAEEF3EQ27014791-206485DD-752B-46CE-8968-E788E8C58F29Q31162702-0C3A071D-7E43-4E2C-897E-91C88A883B28Q33672569-6F476883-1678-44B4-8FC4-1F448532F86EQ33689543-DE88D7DE-8E34-42C2-9FD4-1B5F757CF11EQ33699415-A2229E1C-3D59-431C-A34C-06EDECCC58DBQ33719330-A7E1D644-44BD-4AAB-B7F2-D00B91581971Q33775095-58652E10-A898-4C9D-A795-5CB3B0D9BD79Q33872248-98CA5BE9-68E9-4FB9-88C4-933EB052CDB0Q34311853-F74B33C1-A971-4A4C-A9B4-A806EF7A0A42Q34477459-87C59010-583E-40FB-9A37-3DE846D09DD0Q34483878-F3C47343-061B-4B32-B287-BB0ECE8C527AQ34651135-7553106F-475D-4EBF-891F-FB0892DF8397Q34717480-351EA935-A306-4B73-9DF7-14E59F6B10CCQ34756558-26788466-AE2F-425C-99D0-20921F2C3A05Q34849048-1D99E800-8F7A-48B4-84C6-E0332EEDE7D4Q35229601-F4DFA938-3231-46A6-8D50-4C226AC04E85Q35722468-74E00459-6FBD-4BD3-9FEA-1497B10FBD1AQ35739678-FE2E1010-F972-4FD1-B529-7C5A781FD145Q36005633-0E37273B-F294-458F-86EA-524F17B06A44Q36083501-48B2CB26-4C48-40E1-9364-B5371AF65FA3Q36240571-7318EC88-531B-4848-920C-4E6C78A4022EQ36330933-964510D5-780C-455E-AC05-40C6534A73ACQ36374970-9E984D08-A440-4D76-A9EA-3F044353E43DQ36424857-4F7798F6-C7D5-435B-96F9-C505F2FA54D3Q36426322-170683E5-CA23-48EF-882B-6FF0507D7BC8Q36456068-9B351E7C-C1D8-432F-9D88-04EF6D0C52B9Q36457001-2C3989FE-2CBE-4712-8C51-E29B8E8EFA96Q36510006-756DDC27-8815-4434-93E7-E111633D5274Q36510817-36FF034C-F2C2-44D6-AB85-DE6E96FB5283Q36526176-B97CC19A-2EA8-4001-A31B-6A2804630846Q36622848-C3EC27C9-AA3D-4000-A07D-23963AC34839Q36662808-B499D07B-E282-49EA-85C0-4AAFB6DC8B83Q36687669-A954E8C4-5F9D-460E-B26F-F2F1418FA2ACQ36736127-AED18A93-4402-427A-8305-A3E74773ABEEQ36758718-D8A61403-A238-4DBB-BC1B-44EAA6E7C846Q36813484-3A479D4A-F933-428D-A339-63C6DE2B86E4Q36827330-7910DC0B-5B9E-41EF-A4C9-72CA79EF1D8A
P2860
APOE modifies the association between Aβ load and cognition in cognitively normal older adults.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
APOE modifies the association ...... gnitively normal older adults.
@ast
APOE modifies the association ...... gnitively normal older adults.
@en
type
label
APOE modifies the association ...... gnitively normal older adults.
@ast
APOE modifies the association ...... gnitively normal older adults.
@en
altLabel
APOE modifies the association ...... ognitively normal older adults
@en
prefLabel
APOE modifies the association ...... gnitively normal older adults.
@ast
APOE modifies the association ...... gnitively normal older adults.
@en
P2093
P2860
P1433
P1476
APOE modifies the association ...... gnitively normal older adults.
@en
P2093
D S Knopman
G M Preboske
M L Senjem
R C Petersen
S A Przybelski
S D Weigand
P2860
P304
P356
10.1212/WNL.0B013E31824365AB
P407
P577
2011-12-21T00:00:00Z